Wescott Financial Advisory Group LLC Takes $201,000 Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Wescott Financial Advisory Group LLC purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 380 shares of the medical research company’s stock, valued at approximately $201,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Meridian Management Co. boosted its position in shares of Thermo Fisher Scientific by 1.3% during the 1st quarter. Meridian Management Co. now owns 9,166 shares of the medical research company’s stock valued at $4,183,000 after acquiring an additional 121 shares during the last quarter. IFP Advisors Inc boosted its position in shares of Thermo Fisher Scientific by 4.1% during the 2nd quarter. IFP Advisors Inc now owns 11,119 shares of the medical research company’s stock valued at $5,658,000 after acquiring an additional 439 shares during the last quarter. Factory Mutual Insurance Co. lifted its position in Thermo Fisher Scientific by 21.6% in the 1st quarter. Factory Mutual Insurance Co. now owns 187,814 shares of the medical research company’s stock worth $85,714,000 after buying an additional 33,314 shares during the last quarter. Alliancebernstein L.P. lifted its position in Thermo Fisher Scientific by 14.2% in the 2nd quarter. Alliancebernstein L.P. now owns 1,092,655 shares of the medical research company’s stock worth $551,212,000 after buying an additional 136,094 shares during the last quarter. Finally, Segment Wealth Management LLC lifted its position in Thermo Fisher Scientific by 5.5% in the 1st quarter. Segment Wealth Management LLC now owns 4,285 shares of the medical research company’s stock worth $1,956,000 after buying an additional 223 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

A number of research firms recently weighed in on TMO. Benchmark began coverage on Thermo Fisher Scientific in a research report on Friday, July 16th. They issued a “buy” rating and a $580.00 target price for the company. BTIG Research boosted their target price on Thermo Fisher Scientific from $590.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, July 29th. Zacks Investment Research cut Thermo Fisher Scientific from a “hold” rating to a “strong sell” rating and set a $491.00 price target on the stock. in a research note on Monday, July 12th. Argus lifted their price target on Thermo Fisher Scientific from $530.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, August 4th. Finally, KeyCorp lifted their price target on Thermo Fisher Scientific from $520.00 to $555.00 and gave the stock an “overweight” rating in a research note on Monday, July 12th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eighteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $547.95.

TMO stock traded up $1.80 during midday trading on Wednesday, hitting $564.20. The stock had a trading volume of 25,202 shares, compared to its average volume of 1,587,995. The firm has a market cap of $221.97 billion, a price-to-earnings ratio of 26.07, a price-to-earnings-growth ratio of 1.33 and a beta of 0.74. The business has a 50-day moving average of $542.01 and a two-hundred day moving average of $494.08. Thermo Fisher Scientific Inc. has a 52-week low of $412.80 and a 52-week high of $575.63. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.78 and a quick ratio of 2.11.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 28th. The medical research company reported $5.60 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $5.51 by $0.09. Thermo Fisher Scientific had a return on equity of 29.43% and a net margin of 22.47%. Research analysts predict that Thermo Fisher Scientific Inc. will post 22.07 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 15th. Investors of record on Wednesday, September 15th will be paid a $0.26 dividend. The ex-dividend date of this dividend is Tuesday, September 14th. This represents a $1.04 annualized dividend and a yield of 0.18%. Thermo Fisher Scientific’s payout ratio is 5.32%.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 10,000 shares of the business’s stock in a transaction on Wednesday, August 4th. The stock was sold at an average price of $539.05, for a total value of $5,390,500.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jim P. Manzi sold 572 shares of the business’s stock in a transaction on Friday, July 30th. The stock was sold at an average price of $536.54, for a total value of $306,900.88. The disclosure for this sale can be found here. Insiders own 0.44% of the company’s stock.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific, Inc engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Further Reading: Moving Average – How it Helps Investors in Stock Selection

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.